Published in HPB (Oxford) on May 01, 2010
Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis. World J Gastroenterol (2016) 0.85
Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One (2014) 0.83
Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg (2013) 0.77
Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases. Ann Surg Oncol (2016) 0.75
Novel methods for clinical risk stratification in patients with colorectal liver metastases. Cancer Res Treat (2014) 0.75
Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer. Int J Colorectal Dis (2012) 0.75
The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases. Int J Colorectal Dis (2013) 0.75
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Assessing the generalizability of prognostic information. Ann Intern Med (1999) 8.04
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg (2002) 6.24
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg (2008) 4.86
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol (2001) 3.28
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg (2005) 3.04
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg (2004) 2.65
Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 2.62
Determinants of survival in liver resection for colorectal secondaries. Br J Surg (1986) 2.58
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg (2007) 2.23
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg (2007) 1.85
Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int (2008) 1.83
Repeat hepatectomy for colorectal liver metastases: A worthwhile operation? J Surg Oncol (2001) 1.63
Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg (2003) 1.42
One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg (2003) 1.35
Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg (2007) 1.35
Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg (1999) 1.34
Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol (2000) 1.31
Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg (1998) 1.30
Indicators for treatment strategies of colorectal liver metastases. Ann Surg (2000) 1.26
Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg (2005) 1.26
Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol (2006) 1.23
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer (2007) 1.21
Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 1.15
Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery (2001) 1.12
Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol (2007) 1.12
Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg (2001) 1.09
The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg (2004) 1.08
Repeat hepatic resections for metastatic colorectal cancer. Ann Surg (1994) 1.05
Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg (1996) 1.04
Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 1.02
A review of techniques for liver resection. Ann R Coll Surg Engl (2002) 1.00
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol (2008) 0.99
A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg (2004) 0.95
Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis. Ann Surg (2000) 0.95
Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol (2009) 0.95
Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg (2002) 0.94
Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann Surg (2003) 0.93
Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study. Br J Cancer (2006) 0.93
Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg (2007) 0.91
Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer. Hepatogastroenterology (2001) 0.90
Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 0.88
A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Ann Surg Oncol (2007) 0.82
Surgical resection of colorectal liver metastases. Colorectal Dis (2001) 0.79
Detecting curable disease following hepatectomy for colorectal metastases. ANZ J Surg (2005) 0.79
Systematic review of minimally invasive pancreatic resection. J Gastrointest Surg (2009) 1.21
Retrospective study of patients with acute pancreatitis: is serum amylase still required? BMJ Open (2012) 1.06
The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut (2007) 1.06
Comparison of liver parenchymal ablation and tissue necrosis in a cadaveric bovine model using the Harmonic Scalpel, the LigaSure, the Cavitron Ultrasonic Surgical Aspirator and the Aquamantys devices. HPB (Oxford) (2012) 0.93
Outcomes in patients with indeterminate pulmonary nodules undergoing resection for colorectal liver metastases. HPB (Oxford) (2012) 0.83
Evaluating the role of small-bowel endoscopy in clinical practice: the largest single-centre experience. Eur J Gastroenterol Hepatol (2012) 0.83
Stage IV colorectal cancer: outcomes following the liver-first approach. J Surg Oncol (2013) 0.81
Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection. HPB (Oxford) (2013) 0.80
Percutaneous transhepatic insertion of self-expanding short metal stents for biliary obstruction before resection of pancreatic or duodenal malignancy proves to be safe and effective. Surg Endosc (2009) 0.78
Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases. HPB (Oxford) (2014) 0.77
Two primary tumours metastasizing to the liver in a collision phenomenon. ANZ J Surg (2010) 0.75